Previous studies demonstrated that TLR4/MyD88 activation might up‐regulate STAT3, which accelerates proliferation, metastasis and multidrug resistance of HCC (Kang et al., 2018; F. Wang et al., 2019). The gene discussed is STAT3; the disease is hepatocellular carcinoma.